ArticleAnnals of surgical oncology2026
Comparative Outcomes and Cost-Effectiveness of Robotic Versus Laparoscopic Partial Nephrectomy: A Nationwide Population-based Analysis in Taiwan.
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Robotic partial nephrectomy is inching toward the gold standard for small renal masses-a narrative review.Translational andrology and urology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundThis study evaluated the cost-effectiveness and clinical outcomes of robotic partial nephrectomy (RPN) versus laparoscopic partial nephrectomy (LPN) within Taiwan's National Health Insurance (NHI) system.
methodsA nationwide population-based cohort of renal cell carcinoma patients who underwent partial nephrectomy from January 2021 to August 2024 was analyzed. Covariate balance was achieved by using inverse probability of treatment weighting (IPTW). A Markov model estimated the incremental cost-effectiveness ratio (ICER) over a 10-year horizon, and deterministic and probabilistic sensitivity analyses assessed parameter uncertainty.
resultsAmong 2,675 patients, 1,510 received RPN and 1,165 received LPN. Robotic partial nephrectomy was associated with significantly lower dialysis risk at 30 days (0% vs. 1.18%; 95% confidence interval [CI] for risk difference, -1.9% to -0.5%) and 180 days (0.15% vs. 1.18%, 95% CI -1.7% to -0.2%). Readmission rates were also reduced at 14 days (0.30% vs. 3.10%, 95% CI -4.2% to -2.4%) and 30 days (3.11% vs. 7.23%, 95% CI -5.7% to -2.5%). No significant differences were found in postoperative complications, length of stay, or mortality. Long-term economic evaluation showed that RPN generated 7.31 quality-adjusted life years (QALYs) at a cost of US$22,976.9 compared with 7.29 QALYs at US$30,726.5 for LPN, yielding an ICER of -US$387,480/QALYs. Probabilistic analysis indicated RPN was cost-saving.
conclusionsAlthough RPN involves higher initial procedural costs, it was associated with reduced dialysis risk, fewer readmissions, lower short-term expenditures, and dominant long-term cost-effectiveness. These findings support RPN as a high-value surgical strategy within the NHI system and underscore the need for continued real-world evidence to guide reimbursement policy.
Indexed as
Identifiers
41582287What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.